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Distinguishing between fetal and maternal inflammatory responses is necessary for
understanding the immune interplay either side of the placenta. Fetal immunity reaches
maturity during extrauterine life and while basic inflammatory responses afford a
certain degree of protection, fetuses are vulnerable to infection. With the discovery
of inflammasomes—intracellular scaffolds that facilitate the elaboration of reactions
resulting in the release of mature interleukin-1β (IL-1β)—it is necessary to consider
how inflammatory stimuli are processed. The purinergic P2X7 receptor located on
haematopoietic cells is a key intermediary in signal transduction initiated at Toll-like
receptors (TLR) terminating in release of the mature IL-1β product. We demonstrate
herein that IL-1β release from fetal membranes andmononuclear cells isolated from cord,
placental, and maternal blood, obtained at term, is P2X7- and caspase-1 dependent.
The P2X7-dependent release of the cytokine, which was highest from choriodecidua,
was attenuated by progesterone (P4), prolactin and an NFkB inhibitor. The NLRP3
inflammasome appears necessary for the processing of IL-1β in gestational tissues and
leukocytes.
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Introduction
Preterm birth (PTB) encompasses a spectrum of adverse pregnancy conditions with the
majority being spontaneous in onset (sPTB) and linked to an aggravated inflammatory response
(Goldenberg et al., 2008). Globally, over half of the 2.9 million neonatal deaths are attributed
to infections and complications resulting from PTB (Lawn et al., 2014). Despite several
proinflammatory cytokines being implicated in sPTB, targeting inflammatory pathways either as
biomarkers for predicting the onset of sPTB and its progression or as potential therapeutic targets
has proven difficult as a result of the complex immune interactions at the fetomaternal interface.
Inflammation may be elicited by danger-(damage)—or pathogen-associated molecular patterns,
DAMPs, and PAMPs (Bianchi, 2007) respectively that activate downstream pattern recognition
receptors (PRRs). PAMPs are typically microbial products (e.g., lipopolysaccharide, (LPS)
bacterial/viral DNA) that signal through the family of membrane-bound Toll-like receptors
(Takeda and Akira, 2005). In contrast, DAMPs although similarly diverse, include host-derived
molecules such as ATP but also crystalline/particulate matter that may be of endogenous or
exogenous origin. Many of the signaling cascades activated by PAMPs and DAMPs converge
onto a multiprotein complex, the inflammasome which mediates a series of intracellular reactions
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terminating in the processing of the master proinflammatory
cytokine interleukin (IL)-1β (Martinon et al., 2002; Tschopp et al.,
2003) Inflammasome activation itself results from the assembly
of individual proteins of which the NOD-like receptor (NLR)
entity containing a pyrin domain (NLRP), ASC (apoptosis-
associated speck-like protein with CARD domain) and pro-
caspase-1 are in most cases, necessary components (Martinon
et al., 2002; Tschopp et al., 2003). To date, four distinct
types of inflammasomes, based on the central NLR have been
characterized (Schroder and Tschopp, 2010) of which the NLRP3
inflammasome is of particular interest to us given its activation
by an array of PAMPs and DAMPs implicated in PTB (Khan and
Hay, 2014).
Unlike most cytokines, IL-1β is a leaderless protein, post-
translational proteolytic cleavage of which is required for the
release of its mature 17 kDa form (Perregaux and Gabel, 1994)
and inmonocytes occurs rapidly on inflammasomes. The latter in
pregnancy has been little studied to date but some observations,
for example, raised levels of the DAMP, high mobility group
box-1, HMGB-1 (Romero et al., 2011) point tentatively to
inflammasome involvement. Amniotic fluid caspase-1 levels
have also been shown to be highest in women with sPTB
with confirmed intrauterine infection compared with women
throughout pregnancy without infection (Gotsch et al., 2008)
while monosodium urate (a DAMP linked with the lysosmal
damage pathway of NLRP3) causes increased IL-1β production
in trophoblasts (Mulla et al., 2011).
The NLRP3 inflammasome is triggered in part by toxins
including lipopolysaccharide (LPS) stimulation of TLRs
(Mariathasan et al., 2006). Expression of TLR4 in the human
placenta was first reported in trophoblasts covering peripheral
chorionic villi (Holmlund et al., 2002). TLR4 immunoreactivity
is increased in placentae of preterm cases with chorioamnionitis
compared with those of preterm or term placentae without
chorioamnionitis (Kim et al., 2004). However, in human
myometrium, expression of TLR4 was unchanged in laboring
samples (Youssef et al., 2009) in contrast to results from a mouse
model showing a significant increase in TLR4 expression in
laboring compared with non-laboring myometrium. Expression
of TLR4 has also been reported in preterm and term placentae
of normal women and those with chorioamnionitis (Kumazaki
et al., 2004) and in myometrium and decidua (Krikun et al.,
2007).
A well-characterized route linking TLRs with the NLRP3
inflammasome is via an ATP-gated purinergic receptor, P2X7
(Mariathasan et al., 2006) which we have previously shown
to be expressed and functional in cord blood mononuclear
cells (CBMCs) (Warren et al., 2008). While TLR4 leads to
increased synthesis of mRNA for the precursor form of IL-
1β, processing to its mature and releasable form is reliant
upon the exit of K+ from cells—a role performed by the P2X7
receptor (Kahlenberg et al., 2005). Thus, while numerous studies
have shown links between TLR4 and LPS to cytokine release,
stimulation with ATP increases IL-1β release further through the
P2X7-receptor andmay be a missing ingredient in understanding
sPTB. The aim of our study was to investigate whether key
players in the inflammasome pathway are implicated in the
release of IL-1β from mononuclear cells purified from maternal,
placental, and cord blood obtained at term and in gestational
tissues.
Materials and Methods
Patient Recruitment and Sample Collection
Ethical approval for the study was obtained from the Derbyshire
Research Ethics Committee (Ref: 09/H0401/90). All myometrial,
placental, and blood samples were obtained from patients
attending the Department of Obstetrics and Gynaecology,
Royal Derby Hospital. Patients provided informed, written
consent prior to undergoing either a normal vaginal delivery
or elective cesarean section (CS) at term gestation (> 37
weeks). Blood samples from normal deliveries were assigned as
labor (L) while those from elective CS were designated non-
labor (NL). Indications for elective cesarean section included
maternal request, previous elective CS or breech presentation
while cases with diabetes, hypertension, pre-eclampsia, were
excluded. Placentae, once checked by the midwife and with
the cord clamped, were transported to the lab within 20min
of delivery. Approximately 10–20ml of cord blood were
immediately harvested from the umbilical vein, dispensed into
suitable aliquots into sterile heparinized tubes (BD vacutainer
LH PST™ II) and mixed gently to prevent coagulation. For
collection of placental blood (from the intervillous space), the
placenta was gently squeezed, the pooled blood between the
placental cotyledons collected and added to heparinized tubes.
Maternal peripheral blood samples (10ml) from the median
cubital vein were taken by a registered midwife from pregnant
women attending antenatal clinic and dispensed into tubes
(BD vacutainer LH PST™ II) following transfer to the lab for
processing.
Isolation of Mononuclear Cells from Blood
Samples
Mononuclear cells were isolated from cord blood (CBMC),
placental blood (PLBMC) and maternal blood (MBMC) using
Histopaque R© density gradient medium. Ten ml of heparinized
cord blood were diluted with 10ml of serum free RPMI
(RPMI 1640 medium + 5mM L-glutamine (Invitrogen, Paisley,
Scotland). Then, 10ml of diluted blood was gently layered onto
an equal volume of Histopaque R©-1077 medium followed by
centrifugation at 400 × g for 30min at room temperature.
After centrifugation, the opaque middle layer consisting of
leukocytes was then transferred into a new tube, RPMI added
(without serum) and the cell suspension centrifuged again
at 250 × g for 10min at room temperature. Following this
step, 1ml of red blood cell lysing buffer (Hybri-max R© liquid,
Sigma-Aldrich, Poole, UK) was added to the cell pellet and
mixed for 1min before 10ml of RPMI was added followed
by centrifugation at 250 × g for 10min at room temperature.
After aspirating the supernatant, the pellet was resuspended in
1ml of RPMI, cell counts performed using a haemocytometer
and viability of purified cell preparations assessed using trypan
blue. MBMCs and PLBMCs were also isolated using this
protocol.
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Stimulation and Cytokine Detection
Isolated CBMCs, PLBMCs, and MBMCs were plated at a
density of 1–5 × 106 cells/ml in 24 well plates and cells
left to adhere overnight at 37◦C in a CO2 incubator.
On the following morning, culture media were aspirated
prior to priming cells with 1µg/ml−1 lipopolysaccharide
(LPS) in RPMI for 4 h. The effects of a range of agonists
and antagonists were tested by preincubating cells with
the test chemical during LPS stimulation but prior to the
addition of ATP. Thus, after 2 h of incubation with LPS,
drugs were added to corresponding wells. Half an hour
before the end of the 4 h total incubation period, 200 nM
(3′-O-(4-benzoyl)benzoyl-adenosine 5′-triphosphate (BzATP)
was added to each well to initiate IL-1β release. Controls
consisted of unstimulated cells (without LPS + BzATP)
maintained in culture media or with vehicle (dimethyl sulfoxide
or ethanol). After incubations, supernatants were removed,
centrifuged to remove cell debris, and aliquots frozen at −20◦C
until required for quantitation of IL-1β release by enzyme-
linked immunosorbent assay (ELISA; Quantikine human IL-
1β ELISA kit; R&D Systems, Abingdon, UK). ELISAs were
performed according to the manufacturer’s instructions. The
sensitivity of the assay was <1 pg/ml−1, with an interassay
variability of 4.9% (coefficient of variation) over 20 assays
and does not distinguish between pro–IL-1β and IL-1β. The
concentrations of LPS, progesterone (P4) and prolactin and time
of incubation were determined empirically. The drugs tested
were LPS (TLR4 agonist), BzATP (P2X7 receptor agonist), oATP:
oxidized ATP (P2X7 inhibitor), KN-62 (non-competitive P2X7
antagonist), YVAD-CHO (caspase-1 inhibitor), 100 nM N4-[2-
(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine (QNZ; NFkB
inhibitor; Tobe et al., 2003).
Flow Cytometry
Primary antibodies (CD45, CD14, CD68; all from Abcam,
Cambridge, UK) were added to 100µl samples of CBMCs,
PLBMC, and MBMCs into 4ml EDTA tubes. Tubes were
vortexed for 5 s then left in the dark for 30min followed by the
addition of FITC-labeled secondary antibodies. Cells were then
fixed in 500µl of Optilyse C Solution (Beckman Coulter, High
Wycombe, UK) added to all tubes which then were vortexed and
left for 10min. The final step was to add 500µl of PBS to all
tubes, followed by 100µl of counting beads. The prepared tubes
were left overnight at 4◦C then analyzed using a BeckmanCoulter
FC500 flow cytometer. The bead count number was inserted
into the protocol and the samples run on a low/medium speed.
Gating criteria were set and data analyzed using WinMDI 2.8
software.
Western Blotting
Snap-frozen myometrial biopsies (0.5 g wet weight) and
choriodecidua (0.5 g wet weight) were homogenized on ice
in homogenization buffer (pH 7.8) consisting of sucrose
(320mM), Tris (10mM), KCl (50mM), EDTA (1mM), Igepal
0.5% and 1/500 and 1/100 respective dilutions of protease
inhibitor cocktail and 1/100 dilutions of phosphatase inhibitor
cocktail (Sigma-Aldrich, Poole, UK). The resulting homogenate
was then sonicated for 15min followed by shearing through
a 21 g needle. Samples were then centrifuged (1500 g at
4◦C for 10min), the resulting supernatant collected and
centrifuged again (14,000 g at 4◦C for 1 h) then frozen at −80◦C
for western blotting. Preparations of CBMC, PLBMC, and
MBMC (10 million cells/ml of each sample) were prepared
for western blotting using two rounds of a freeze-thaw cycle
then passing through a 21 g needle as for myometrium and
choriodecidua.
For SDS-PAGE, lysates of choriodecidua, myometrium,
and leukocytes were diluted with Laemmli buffer (BioRad,
Hemel Hempstead, UK) containing 5% β-mercaptoethanol.
Approximately 10µl of each sample were loaded and
electrophoresed for 50–60min at 40mA. The wet transfer
onto nitrocellulose membranes was carried out using a
BioRad Miniprotean III system for 2 h at 100V at 4◦C. After
electroblotting and confirmation of equal loading and transfer
of proteins with Ponceau S red solution, (Sigma-Alrich, Poole,
UK), blots were washed with distilled water three times then
blocked in 5% Marvel milk protein in TBS for 1 h followed by
probing with primary antibodies against TLR4, P2X7, prolactin
receptor (Abcam, Cambridge, UK) and the P4 receptor (Abcam,
Cambridge, UK). Antibodies were prepared in 3% Marvel
milk/TBS, added to each blot at the appropriate dilution and
membranes left shaking gently overnight at 4◦C then washed
the next day to remove any unbound antibody. Alkaline
phosphatase-conjugated secondary antibody (diluted in 3%
Marvel milk protein/TBS) was then added to immunoblots
for 2 h at room temperature. Protein bands were detected
using the non-isotopic chemiluminescent detection system
Immuno-star-Alkaline Phosphatase (AP) kit (BioRad, Hemel
Hempstead, UK), viewed using the Chemi Doc (version 4.2.1)
imaging system. Blots were then stripped using Reblot Plus
(Millipore) for 12min and re-probed to measure β-actin
expression as a loading control where it was used for qualitative
purposes only.
Immunofluorescence
Culture media frommononuclear cell preparations was removed,
cells washed with PBS followed by fixation in a 1:1 mix of ice-cold
acetone:methanol mixture for 10min. Following three further
washes with PBS, 20% goat serum was added to each well and
plates incubated for 30min at room temperature on a shaking
platform. Then 200µl of corresponding antibody prepared
in 20% goat serum were added to corresponding wells after
aspiration of blocking solution and plates incubated overnight
at 4◦C with shaking. On the next day, primary antibodies were
removed and each well-washed with 1ml of PBS for 10min,
three times. Secondary fluorescein isothiocyanate (FITC)-labeled
antibodies (Abcam, Cambridge, UK) were made in blocking
solution with 250µl of secondary antibody added to each well.
The plates were then covered in foil and incubated with shaking
for 30min at room temperature. Secondary antibodies were then
aspirated and the wells washed with 1ml of PBS for 10min, three
times. Finally, 1ml of PBS was added to each plate which was then
examined in a dark room with a Ziess Axiovert 25 fluorescence
microscope and photographed (Olympus DP70 digital camera)
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and Cell F software. Addition of control IgG instead of the test
primary antibody enabled specific from non-specific staining to
be identified and was included in all immunofluorescence/flow
cytometry experiments.
For indirect immunofluorescence staining for surface and
transmembrane proteins by flow cytometry, between 100 and
500µl of cell suspension containing 5 × 106 cell/ml of
purified mononuclear cells were aliquoted into labeled test
tubes as required including a tube with neat cell suspension
(control), another with primary antibody (to assess antibody
concentration) and a tube with secondary antibody alone
(negative control). Following addition of the appropriate primary
antibody, tubes were incubated at room temperature for 60min
followed by washing of cells by adding 1ml of PBS/BSA then
centrifuging at 300 g for 5min. The resulting supernatant was
carefully removed an appropriate dilutions of the secondary
antibody added to corresponding tubes and mixed well following
incubation at room temperature for 30min. After washing
with PBS/BSA, solutions were centrifuged at 300 g for 5min,
the supernatants discarded and cells fixed in 1ml of 4%
paraformaldehyde for 10–15min at 4◦C. Cells were washed again
with PBS/BSA buffer, and centrifuged at 300 g for 5min then
resuspended in 500µl of PBS/BSA then data was acquired by flow
cytometry.
Cytokine Release from Intact Membranes Using
Transwells
Full-thickness gestational membranes comprising amnion,
chorion and decidua were dissected intact under sterile
laboratory conditions. The membranes were examined to ensure
that the amnion and choriodecidua remained attached to one
another. Culture medium consisted of RPMI supplemented
with 1% (v/v) heat inactivated-fetal bovine serum, 100 units
penicillin/ml, and 100µg streptomycin/ml (Zaga et al., 2004;
Thiex et al., 2009, studies, 2010). Full-thickness gestational
membranes were cultured using a Transwell two-chamber
tissue culture. The membranes were cut into approximately
2 × 2 cm2 pieces, affixed by elastic latex bands onto ethylene
oxide sterilized Transwell frames (with the synthetic membrane
removed). The outer 2 cm of the gestational membranes was
excluded from experimentation. Membranes were studied
intact with drugs added directly to the upper chamber
with choriodecidua uppermost. Experiments were also
conducted with the amnion uppermost. Fetal membranes
in the Transwell assembly were maintained over 24 h then
challenged as described for cells with LPS followed by BzATP,
the latter being added 30min before the end of the stimulation
protocol.
Statistical Analysis
Results are expressed as mean± SD. Quantitative data generated
by ELISA were analyzed with Prism V6 software (Graphpad).
Statistical analysis was carried out using one-way analysis of
variance with post-hoc Bonferroni correction, the Kruskall-Wallis
test for non-parametric data and paired t-test for comparison
between L and NL groups. A value of P < 0.05 was considered to
indicate statistical significance.
FIGURE 1 | Leukocyte populations in fetal and maternal blood. (A)
Differences between cell marker expression in preparations of MBMCs,
CBMCs, and PLBMCs using flow cytometry (n = 6–10 in each group).
Leukocyte count in whole cord venous blood of L group and NL group was
significantly different between the two the groups (P < 0.05). (B) Scatter plot
showing the percentage of CBMCs, PLBMCs, and MBMCs expressing (B)
CD45, (C) CD14, and (D) CD68, determined by flow cytometry.
Results
Characterization of Cells in Whole and Purified
Cord Blood
Whole blood from the umbilical vein and intervillous space of
the placenta L (n = 6–10) and NL (n = 6–10) was analyzed
by flow cytometry. The total leukocyte count (Figure 1A) was
in the range 10.64–28.82 × 109/L in L group compared with
7.19–20.45 × 109/L in NL group (P < 0.05). Figure 1 shows
that CBMCs and MBMCs expressed higher amounts of the
pan-leukocyte marker CD45 (Figure 1B), the monocyte markers
CD14 (Figure 1C) and CD68 (Figure 1D) than PLBMCs (P <
0.05) while proportions between CBMCs and MBMCs were
similar (P > 0.05). Flow cytometry data based on scatter and
fluorescence for CD45, CD14, and CD68 is shown in Figure 2.
TLR4 and P2X7 Expression in Mononuclear Cells,
Myometrium, and Choriodecidua
CBMCs (n = 8) and PLBMCs (n = 7) expressed both
TLR4 (Figure 3A) and P2X7 receptor (Figure 3B) proteins as
detected by immunofluorescence along with MBMCs (data not
shown). Western blotting further corroborated the presence of
TLR4 immunoreactivity in PLBMCs (n = 7) and CBMCs
(n = 7) as well as expression in myometrium (n = 5) and
choriodecidua (n = 5) of NL (Figure 3C) and L samples (Data
not shown). P2X7 receptor expression was clearly detectable with
bands of high intensity of the expected molecular weight (74–
78 kDa) in myometrium, choriodecidua, PLBMCs and CBMCs
(Figure 3D). Flow cytometry showed that some 55.0% of CBMCs
express TLR4 (n = 7) while more than 80% of these cells
express P2X7 (n = 7; Figure 3E). In PLBMCs, the results
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FIGURE 2 | Dot plot of leukocyte markers in isolated cells. Cells were
prepared for flow cytometry then analyzed using fluorescence leukocyte
markers CD45 (A), CD14 (B) and CD68 (C). Levels of CD14 (B) were lowest
in PLBMCs, CBMCs, and MBMCs. (D) Dot plot for MBMCs.
were comparable to those in CBMCs where 47.8% of cells
express TLR4 while a similarly higher number (70.8%) of cells
express P2X7. CBMCs responded to LPS (0.1–1000µgml
−1)
by producing concentration-dependent release of mature IL-1β
detectable in cell supernatant (n = 4; Figure 3F) and informed
our dose of LPS in the study.
In order to examine a role for NLRP3 in the production
of IL-1β, MBMCs (n = 5), CBMCs (n = 5) and PLBMCs
(n = 5) from the NL group were tested unstimulated and
following stimulation with 1µg/ml LPS. In contrast to MBMCs
(Figure 4A, left hand panel) and PLBMCs (Figure 4A; right hand
panel), unstimulated CBMCs did not express NLRP3 but it was
induced following stimulation with LPS + BzATP (Figure 4B,
middle panel). Flow cytometry (n = 5) confirmed positive
immunofluorescence for NLRP3 in CBMCs (92.4%) following
induction with LPS + BzATP (Figure 4B) compared with a lack
of expression in control, unstimulated cells.
The Role of TLR4 and P2X7 in Triggering of IL-1β
Secretion in CBMC
Stimulation of TLR4 in CBMCs (n = 8) and PLBMCs (n = 8)
with LPS and LPS + BzATP triggered the production of IL-1β in
cell supernatant in both L and NL groups and was significantly
higher in the L group (P < 0.05) in both preparations
(Figures 5A,B). The P2X7 agonist BzATP alone had no effect on
IL-1β release from either CBMCs or PLBMCs compared with
control, unstimulated cells (Figures 5A,B; n = 6–10 in cases). To
evaluate further, the individual role of the P2X7 receptor in IL-1β
release, preincubation with the P2X7 antagonists 10µM KN-62
(Warren et al., 2008) alone to cells stimulated with LPS+ BzATP
inhibited IL-1β release (P < 0.05) by over 60% (Figures 5A,B).
IL-1β release in both CBMCs and PLBMCs was also significantly
attenuated by the caspase-1 inhibitor YVAD-CHO to a similar
extent between the L and NL groups in CBMCs and PLBMCs
FIGURE 3 | Expression of TLR4 and P2X7 proteins in gestational
tissues. (A) CBMCs and PLBMCs express TLR4 (anti-TLR4 antibody at
1:200); (B) CBMCs and PLBMCs express the P2X7 receptor (anti-P2X7
antibody at 1:200). Immunofluorescence was detected using
fluorescence-tagged secondary antibodies following fixation and incubation
with a primary antibody. No background fluorescence was visible in cells that
had been preincubated with control IgG instead of the primary antibody (C)
Representative western blots obtained using lysates prepared from
myometrium (M; n = 5), choriodecidua (D; n = 5), PLBMCs (n = 7), and
CBMCs (n = 7) identifies an 85 kDa using anti-TLR4 antibody and (D) an
anti-P2X7 antibody that recognizes 74–78 kDa protein. (E) Using flow
cytometry, a higher percentage of CBMCs (n = 7) expressed the P2X7
receptor (80.2%) compared with TLR4 where 55.0% were positive (n = 7). (F)
Concentration-dependence of IL-1β release in response to LPS from CBMCs.
on LPS + BzATP stimulation. A combination of YVAD-CHO
and oATP produced a greater inhibition of IL-1β release than
either agent applied alone in cells of both L and NL groups
(Figures 5A,B).
In CBMCs and PLBMCs preincubated with P4 (1µM) and
stimulated with LPS + BzATP, a significant reduction in the
release of IL-1β was noted (Figures 5A,B) which was greater
in PLBMCs (Figure 5B) and in L (n = 6) relative to the NL
group (n = 6; P < 0.05). The effects of P4 were dose-
dependent (10−8–10−5 M, data not shown). Prolactin (1µM),
also in cells prestimulated with LPS + BzATP, inhibited IL-
1β release from CBMCs (Figure 5A) and PLBMCs (Figure 5B)
in L and NL women with no differences noted between L
and NL samples. Repeating the experiment in the presence
of QNZ (200 nM) also demonstrated significant inhibition in
cells from L (n = 4) and NL women (n = 4; data not
shown).
The Role of TLR4 and P2X7 in Triggering of IL-1β
Secretion in MBMCS
MBMCs displayed a similar response to LPS and BzATP to that
observed in CBMCs and PLBMCs. As is evident in Figure 6A, IL-
1β release provoked in MBMCs was consistent with that noted in
CBMCs and PLBMCs (Figure 5). LPS alone increased the IL-1β
released from baseline in the control group which was doubled by
LPS+ BzATP but reduced in the presence of YVAD-CHO in cells
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FIGURE 4 | Expression of NLRP3 in MBMCs, PLBMCs, and CBMCs.
(A) Expression of P2X7 was detected by immunofluorescence in MBMCs (LH
panel), CBMCs (middle panel) and PLBMCs (right hand panel) with CBMCs
requiring prior incubation with LPS + BzATP before NLRP3 was detectable.
(B) Flow cytometry demonstrated that costimulation with LPS + BzATP
resulted in 92.4% of CBMCs showing NLRP3 expression as seen in the single
parameter histogram.
preincubated with LPS+ BzATP (Figure 6A). The effect of QNZ
was less than that of YVAD-CHO (Figure 6A). Interestingly, both
P4 and prolactin partially inhibited the LPS + BzATP-mediated
increase in IL-1β (Figure 6A).
Western blotting provided evidence for expression of the
P4 receptor in choriodecidua and PLBMCs but not CBMCs
(Figure 6B; n = 6 for all) while prolactin receptor protein
was undetectable in CBMCs in contrast to myometrium,
choriodecidua and a faint signal in PLBMCs (n = 6; data not
shown).
In order to determine whether fetal membranes play a role
in the release of IL-1β, intact membranes in transwells were
incubated with test agents applied to the choriodecidual surface
and IL-1β in the upper chamber measured by ELISA. IL-1β
release was highest in membranes stimulated with LPS+ BzATP.
In the presence of the latter, 10µM KN-62 (n = 5), YVAD-
CHO (n = 5), 10−5M P4 (n = 8), 1µM prolactin (n =
6) and 200 nM QNZ (n = 6) all caused inhibition of IL-
1β secretion consistent with effects noted in CBMCs, PLBMCs
and MBMCs with the largest degree of inhibition seen with
KN-62 and YVAD (Figure 7A). It was also apparent that fetal
membranes from laboring women produced higher amounts of
IL-1β than the NL group for all treatments except with KN-
62 inhibition (Figure 7A). Interestingly inhibition with prolactin
was greater in fetal membranes than isolated mononuclear cells.
When LPS + BzATP were coapplied to the upper chamber with
amnion uppermost, IL-1β was produced in the upper chamber
with only low amounts detected in supernatant sampled from the
lower chamber over 24 h (P < 0.05; n = 6; Figure 7B). Similar
effects were observed with choriodecidua uppermost (Figure 7C;
n = 6).
FIGURE 5 | CBMCS and PLBMCs from laboring (L) and non-laboring
(NL) women incubated with LPS and BzATP leads to increased IL-1β
release. Costimulation with LPS and BzATP led to increased release of IL-1β
than either LPS or BzATP alone from (A) CBMCs and (B) PLBMCs. Cells from
laboring women produced significantly greater amounts of IL-1β. IL-1β release
was inhibited following preincubation with the P2X7 antagonists KN-62, oATP
and the caspase -1 inhibitor YVAD-CHO following costimulation with LPS and
BzATP as indicated on graphs by a “+” prefix before treatment. A combination
of YVAD and oATP led to greater inhibition of IL-1β than either inhibitors alone,
Both LPS and BzATP_evoked IL-1β release which was inhibited by P4 and
prolactin in (A) CBMCs and (B) PLBMCs. (*P < 0.05).
Discussion
The P2X7 receptor provides an intriguing link in transducing
the signals elicited by bacterial endotoxin via the TLR4 receptor
and the secretion of the cytokine IL-1β (Colomar et al., 2003;
Kahlenberg et al., 2005; Mariathasan et al., 2006), previously
shown to be raised in PTB (Romero et al., 1989, 1992). In relation
to pregnancy, the function and physiology of P2X7 receptors
in gestational tissues and immune cells at the fetomaternal
interface are not known. We have previously reported on the
role of the P2X7 receptors in CBMCs (Warren et al., 2008) and
herein confirm P2X7 receptor expression in PLBMCs, MBMCs,
myometrium, and choriodecidua. Our results also verify protein
expression of TLR4 in myometrium (Dallot et al., 2005; Youssef
et al., 2009) and choriodecidua (Krikun et al., 2007) as well as
CBMCs and PLBMCs as reported for myeloid cells in pregnancy
(Youssef et al., 2009).
A key finding of our study is that the largest increase in
release of IL-1β from CBMCs, PLBMCs, and MBMCs, is evoked
by costimulation with LPS and the P2X7 agonist, BzATP, and is
maximally inhibited in the presence of the caspase-1 inhibitor
YVAD-CHO implicating inflammasomes in release of IL-1β.
Indeed, our finding of NLRP3 inflammasome expression in
PLBMC and MBMCs in the absence of stimulation with LPS
and BzATP implies constitutive expression of this protein. In
contrast, CBMCs did not express the NLRP3 inflammasome
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FIGURE 6 | IL-1β release from maternal blood mononuclear cells
(MBMCs). (A) Coincubation with LPS and BzATP elicited greater production
of IL-1β from MBMCs. P4, prolactin, the NFkB inhibitor QNZ and the
caspase-1 inhibitor YVAD-CHO all inhibited IL-1β release. (B) Western blotting
showed positive expression for the P4 receptor in choriodecidua (CD; n = 6),
some expression in PLBMCs (n = 6) but undetectable levels in CBMCs
(n = 6). *P < 0.05 when compared using Dunnett’s test.
unless primed with LPS or a combination of LPS and BzATP. We
also observed constitutive expression of ASC protein in CBMCs,
PLBMCs, and MBMCs (data not shown). A possible explanation
for these observations is that the NLRP3 inflammasome is
already functional in PLBMCs since the latter isolated from the
intervillous space derive largely from the maternal circulation
and are likely to be a mix of cell types including maternal
leukocytes and fetal macrophages (Hofbauer cells) compared
with relatively immature fetal monocytes cells that comprise cord
blood; this also explains the lower percentage of CD14+ and
CD68+ cells in the PLBMC preparation.
Recently, it was reported that the ability of CBMCs to secrete
IL-1β is dependent on a high CD14-expressing monocyte subset
producing pro-1L-1β but characterized by impaired release of
IL-1β attributed to low expression of NLRP3; P2X7 and pro-
caspase-1 expression were comparable to adult levels (Sharma
et al., 2015). Sharma et al., also found that a low CD14-expressing
monocyte subset, abundant prior to 33 weeks of gestation, was
incapable of producing IL-1β following costimulation with LPS
and ATP (Sharma et al., 2015). They were also able to show
that high CD14-expressing monocyte subset obtained at term
required stimulation with LPS before NLRP3 could be detected
(Sharma et al., 2015) and agrees with our observations that
CBMCs required priming by LPS for translation of NLRP3.
Leukocyte trafficking to the uterus is increased with
parturition (Thomson et al., 1999; Osman et al., 2003) which
led to us further investigate the P2X7 pathway in gestational
membranes based on the fact that the receptor is expressed
abundantly in immune cells. Stimulation of IL-1β release was
tested using intact disks of fetal membranes ex vivo using the
two-chamber transwell model (Zaga et al., 2004). Our finding that
IL-1β release from intact fetal membranes cases is mediated by
the P2X7 receptor pathway reflects data obtained from isolated
CBMCs and PLBMCs. In a recent study using fetal membranes
and myometrium obtained prior to and after the onset of labor, a
potential role for the inflammasome was inferred from increased
gene transcription of caspase-1 (Lappas, 2014). Moreover, using
explants of membranes and myometria, LPS and ATP stimulated
IL-1β production which was further enhanced with nigericin
and inhibited using KN-62 (Lappas, 2014). Fetal membranes
have also been shown to express all ten human TLR subtypes
in addition to NLRP1, NLP3, ASC, and caspase-1 (Hoang et al.,
2014). In the latter study, it was also shown that active IL-1β
levels were higher from fetal membranes after stimulation with
PAMPs including LPS with IL-1β only noted on stimulation
with TLR-2, -4 and, -5 ligands (Hoang et al., 2014). In our
study, consistent with previous findings (Zaga et al., 2004),
stimulation of choriodecidual membranes with LPS produced
elevated IL-1β production in response to LPS compared with
amniotic membranes suggesting that the choriodecidual side of
gestational membranes appears more responsive to TLR4 and
P2X7 stimuli compared with the amnion. Others have shown
that treating the choriodecidual side of the membrane leads to
production of IL-6, IL-10, IL-8, and TNF-α levels in the same
compartment while only TNF-α and IL-6 levels were found
in the lower compartment (Thiex et al., 2009); levels of IL-1β
were not statistically significant irrespective of LPS application
to either amniotic or choriodecidual aspects (Thiex et al., 2009).
In other studies and in agreement with our data, IL-1β release
was higher from the choriodecidual side (Pineda-Torres et al.,
2014). A greater range and amount of cytokines produced by
choriodecidua is not surprising, given that this barrier likely
mounts a stronger response in providing protection for the
fetus from maternal infection. A similar effect is seen for TLR4
receptors that show higher expression in trophoblast membranes
facing maternal blood in the intervillous space (Beijar et al.,
2006).
Based on reduced levels of IL-1β release in leukocytes
and choriodecidual membranes following incubation with P4
(Pineda-Torres et al., 2014), an immunomodulatory role for
this steroid appears justified. As fetal and neonatal CBMCs
lack nuclear P4 receptors, postulated mechanisms for the anti-
inflammatory effects of P4 include actions at membrane P4
receptors (Giannoni et al., 2011), effects on cAMP cascades
(Schwartz et al., 2009) or by inhibition of the NF-κB pathway
(Srivastava and Anderson, 2007; Giannoni et al., 2011). Of
course, P4 may also exert anti-inflammatory effects through
glucocorticoid receptors expressed in cord blood (Imamura et al.,
2011). It is unlikely that P4’s effects are via inhibition of current
through P2X7 receptors given the lack of effect observed with
application of the steroid (Cario-Toumaniantz et al., 1998).
Similar uncertainty exists around the anti-inflammatory effects
we observed with prolactin which attenuated the amount of IL-
1β produced by CBMCs, PLBCs, MBMCs, and fetal membranes
costimulated with LPS and BzATP. A recent finding also noted
inhibition of IL-1β in fetal membranes by prolactin but over a
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FIGURE 7 | Gestational membranes produce IL-1β. (A) Intact
membranes assembled in transwells stimulated with LPS, BzATP, and LPS+
BzATP led to increased IL-1β release which was highest in the latter and from
laboring samples. KN-62, YVAD-CHO, progesterone (P4), prolactin (PRL), and
(QNZ) all caused a reduction in IL-1β release in cells stimulated with LPS +
BzATP combined. (B) Using intact membranes and sampling media on both
sides (upper) and (lower) of the transwell, amnion produced IL-1β only in the
upper compartment (C) when choriodecidua was uppermost and upper and
lower chambers tested for IL-1β production, higher levels of the cytokine were
produced from the upper chamber and were higher than those produced
when amnion was uppermost (n = 6; P < 0.05). IL-1β amounts are expressed
per/cm2. *P < 0.05 comparing each treatment between NL and L groups.
much longer time course of 32 h (Zaga-Clavellina et al., 2014).
Addition of LPS activated the synthesis of prolactin receptor
mRNA and prolactin mRNA in human monocytes in vitro up
to 300- and 130-fold, respectively (Lopez-Rincon et al., 2013)
and is interesting in the context that human decidua produces
large amounts of prolactin throughout pregnancy (Rosenberg
et al., 1980), that like P4, may play a role in local host-defense
responses.
Extracellular levels of ATP, the natural ligand for the P2X7
receptor, are tightly regulated in vivo but achieve amounts
required for activation of the P2X7 receptor in the presence of
necrosis or tissue injury. This links the P2X7 receptor to events
in the pregnant uterus where levels of extracellular ATP levels
may become elevated through localized tissue damage caused
by the powerful contractions of the myometrium, resulting in
DAMP-dependent inflammasome activation.
Inflammatorymechanisms remain a crucial area of research in
understanding pregnancy disorders particularly the mechanisms
deployed by harmfulmicrobes to breach physical barriers but also
maternal and fetal defenses that are designed to resist infection.
We saw no obvious differences amongst the various preparations
used in this investigation except that higher IL-1β levels were
secreted in cells and tissues isolated from women in labor,
suggesting that the TLR4-P2X7-IL-1β axis is a common pathway
within the uterus and fetal membranes. It has been suggested
that myometrial contractility may result from COX-2 mediated
prostaglandin production induced by inflammatory stimuli that
include IL-1β (Rauk and Chiao, 2000). Coupled with this,
it was demonstrated that overnight incubation of myometrial
strips with IL-1β led to significant release of prostaglandins
(Oger et al., 2002). Alternatively, production of IL-1β via P2X7
receptor activation in immune cells could also drive myometrial
contractility. Indeed, expression of the rat myometrial P2X7
receptor increases prior to labor and in an animal model of PTB,
P2X7 mRNA and protein increased closer to term indicating a
distinct activation of inflammatory pathways (Urabe et al., 2009;
Miyoshi et al., 2010). This group also reported an ATP-activated
conductance, presumed to be P2X7, in rat myometrium (Miyoshi
et al., 2012).
In conclusion, a role for TLR4 and P2X7 receptors in
gestational tissues and cells is suggested. Both were expressed
in leukocytes isolated from cord venous blood but also from
maternal blood in the intervillous space. The expression of P2X7
in human myometrium and choriodecidua provides support for
a P2X7 pathway of potential importance in paracrine interactions
between maternal and fetal systems involving smooth muscle
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as well as immune cells but also fetal membranes. However,
some aspects of fetal immunity appear to be immature as
evidenced by the priming required for NLRP3 expression in
CBMCs but not for PLBMCs and MBMCs. Release of the
cytokine IL-1β via inflammasome activation downstream of
P2X7 activation may enable direct signaling between the amnion
and choriodecidua thereby triggering prostaglandin-mediated
myometrial contractions but may also constitute a first-line of
immune defense to microbes reaching the amniotic cavity by
amniotic production of IL-1β. Differences were observed with
higher levels of IL-1β secreted in cells and tissues derived from
laboring compared with non-laboring samples. The modulation
of IL-1β release by P4, prolactin and an NFkB inhibitor in
mononuclear cells raises the possibility of targeting the P2X7
receptor pathway to limit inflammation and is also a novel
mechanism through which P4may help prevent PTB (da Fonseca
et al., 2003). Currently, there is little direct evidence available
for exaggerated inflammasome activity as a factor in causing
PTB yet clues point to a potential association. Interestingly, a
recent study examining polymorphisms in genes associated with
inflammation observed an altered frequency for the gene CIASI
(NLRP3) indicating a potential genetic predisposition to PTB
(Jaffe et al., 2013). Investigations into studies of the chain of
events involved in inflammasome activation in cases of sPTB
compared with normal parturition may yield further insight into
mechanisms and new targets that enable prediction of PTB.
Specifically, a need to better understand the NLRP3-linked signal
transduction pathways activated by bacterial toxins implicated
in sPTB may help unravel the complexity of inflammatory
mechanisms implicated in fetal demise as a result of being born
too early.
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